YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that ...
YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
TAIWAN, Jan. 29, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ...
TAIWAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ...
Hosted on MSN
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal
Shares of YD Bio drew the attention of retail traders late Sunday following the company’s announcement that it had completed its merger with Breeze Holdings Acquisition Corp, a special purpose ...
Hosted on MSN
YD Bio enters MOU to merge with EG BioMed
YD Bio (YDES)announced that the Company has entered into a Memorandum of Understanding, MOU, to merge with EG BioMed. The MOU is non-binding and there can be no assurance that the parties will enter ...
LOS ANGELES, CA / ACCESSWIRE / July 25, 2019 / Ricki Li, founder of notable real estate investment firm YD Fortune, is building a real estate empire. Starting in Center City Philadelphia, and building ...
YD Bio Ltd’s business model centers on partnerships with biopharmaceutical companies to transform innovative technologies into commercially viable drugs and cancer detection diagnostics. Led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results